 | 39°08′14″N 77°13′36″W / 39.1371°N 77.2267°W / 39.1371; -77.2267 Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland... 31 KB (2,834 words) - 23:08, 24 April 2024 |
 | The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, among others, is a subunit COVID-19 vaccine developed by Novavax and the... 65 KB (4,734 words) - 04:34, 31 March 2024 |
Institute of India has also reached an agreement with Novavax for the production of Novavax's NVX-CoV2373 (Covovax) vaccine for India and other low and... 19 KB (1,601 words) - 21:04, 11 February 2024 |
Sputnik V, Janssen, Covaxin, Moderna, Sinopharm BIBP, Sputnik Light and Novavax. As of February 19, 2023, 166,423,405 total vaccine doses have been administered... 99 KB (8,592 words) - 07:13, 26 March 2024 |
Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi–GSK. Seven others are under assessment by the WHO:... 318 KB (19,351 words) - 20:00, 21 April 2024 |
 | 224-233. doi:10.1007/s12026-018-8991-x Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial. Novavax Press Release, Jan 28, 2021. https://ca... 8 KB (853 words) - 16:17, 26 April 2024 |
| SARS-CoV-2 Beta variant (section Novavax) 2021. Retrieved 20 March 2021. "Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial". ir.novavax.com. 28 January 2021. Archived from... 72 KB (6,070 words) - 06:39, 3 February 2024 |
vaccines to stimulate the immune response. It was patented in 2020 by Novavax and is composed of nanoparticles from saponins extracted from Quillaja... 6 KB (568 words) - 06:48, 16 November 2023 |
Indian-American vaccinologist who leads vaccine development at Novavax. She oversaw the development of the Novavax COVID-19 vaccine. Patel was born in Sojitra, a farming... 6 KB (688 words) - 06:39, 29 November 2023 |
 | 2020. Retrieved December 20, 2020. "Novavax Announces $1.6 Billion Funding from Operation Warp Speed". Novavax. July 7, 2020. Archived from the original... 72 KB (5,994 words) - 15:49, 8 February 2024 |
Emergent BioSolutions (section Novavax) initially teamed with Novavax Inc., a bio-technology company also based in Gaithersburg, MD., in the development and manufacture of the Novavax COVID-19 vaccine... 69 KB (7,277 words) - 13:58, 11 February 2024 |
 | November 2022, the first recombinant protein-based COVID-19 vaccine (Novavax's booster Nuvaxovid) was authorized for use in adults in the United Kingdom... 372 KB (32,316 words) - 04:26, 25 April 2024 |
 | through the COVAX facility under the WHO hospice. A recent agreement with Novavax expands its production for a second vaccine to 40 million doses in 2022... 276 KB (24,990 words) - 03:37, 23 April 2024 |
 | Therapeutic Goods (ARTG). As of 14 June 2021, Novavax had entered the final stage of trials. As of 8 July 2021, the Novavax COVID-19 vaccine was under evaluation... 178 KB (12,119 words) - 03:08, 8 March 2024 |
 | Current vaccines CoronaVac Covaxin Convidecia Janssen Medigen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sinopharm BIBP Sputnik V Variants Variants... 285 KB (32,669 words) - 05:08, 20 April 2024 |
 | COVID-19 vaccination in South Africa (section Novavax) 2021. Retrieved 20 March 2021. "Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial". ir.novavax.com. 28 January 2021. Archived from... 159 KB (11,635 words) - 14:00, 13 February 2024 |
chairman. Subject to regulatory approval, at least 60 million doses of the Novavax COVID-19 vaccine will be manufactured for the UK government from 2021 by... 9 KB (826 words) - 21:46, 26 February 2024 |
 | Corbevax† Bharat Biotech† CanSino† CoronaVac† EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione†... 71 KB (8,601 words) - 23:25, 1 April 2024 |
 | Corbevax† Bharat Biotech† CanSino† CoronaVac† EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione†... 26 KB (2,706 words) - 20:39, 20 February 2024 |
saponin QS21, has been investigated for as an adjuvant for human vaccines. Novavax uses a highly purified quillaja extract as an adjuvant in its veterinary... 3 KB (363 words) - 08:15, 8 November 2023 |
 | Current vaccines CoronaVac Covaxin Convidecia Janssen Medigen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sinopharm BIBP Sputnik V Variants Variants... 90 KB (8,407 words) - 17:14, 21 April 2024 |
 | Corbevax† Bharat Biotech† CanSino† CoronaVac† EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione†... 59 KB (6,125 words) - 01:07, 25 April 2024 |
| Current vaccines CoronaVac Covaxin Convidecia Janssen Medigen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sinopharm BIBP Sputnik V Variants Variants... 347 KB (409 words) - 04:22, 23 April 2024 |
 | Corbevax† Bharat Biotech† CanSino† CoronaVac† EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione†... 139 KB (14,389 words) - 19:40, 15 April 2024 |
China Pharmaceutical Group (1953- ) NovaBay (2000– ) Novartis (1996– ) Novavax (1987– ) Novo Nordisk (1923– ) Noxxon (1997– ) Octapharma (1983– ) Onyx... 17 KB (1,297 words) - 19:32, 24 April 2024 |
 | Corbevax† Bharat Biotech† CanSino† CoronaVac† EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione†... 224 KB (23,768 words) - 18:46, 25 April 2024 |
 | Additionally, many biotechnology companies such as United Therapeutics, Novavax, Emergent BioSolutions, Parabon NanoLabs and MedImmune have headquarters... 81 KB (4,782 words) - 17:09, 26 April 2024 |
 | Corbevax† Bharat Biotech† CanSino† CoronaVac† EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione†... 56 KB (5,189 words) - 16:28, 2 March 2024 |
2020. Retrieved 1 May 2020. "Urgent global health needs addressed by Novavax". Novavax. Archived from the original on 12 May 2021. Retrieved 30 January 2021... 192 KB (21,930 words) - 19:29, 15 April 2024 |
 | purchased two more vaccines from the pharmaceutical companies AstraZeneca and Novavax for New Zealand and its Pacific partners in addition to the existing stocks... 238 KB (18,482 words) - 06:22, 20 April 2024 |